These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 5077040)

  • 1. [Medical treatment of Parkinson's disease].
    Castaigne P; Rondot P; Ribadeau-Dumas JL
    Ann Med Interne (Paris); 1972 Apr; 123(4):357-64. PubMed ID: 5077040
    [No Abstract]   [Full Text] [Related]  

  • 2. [Accomplishment of the treatment and evaluation of treatment alternatives in parkinsonism].
    Presthus J
    Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2119. PubMed ID: 4773985
    [No Abstract]   [Full Text] [Related]  

  • 3. Levodopa and related drugs.
    Med Lett Drugs Ther; 1973 Mar; 15(5):21-3. PubMed ID: 4697470
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of additional medication of Amantadine sulfate in L-dopa-pretreated patients with Parkinson's syndrome (author's transl)].
    Schneider E; Fischer PA; Jacobi P
    Med Klin; 1974 Mar; 69(13):541-5. PubMed ID: 4831456
    [No Abstract]   [Full Text] [Related]  

  • 5. Augmenting the action of levodopa.
    Rao SK; Vakil SD; Calne DB; Hilson A
    Postgrad Med J; 1972 Nov; 48(565):653-6. PubMed ID: 4568331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-dopa therapy in Parkinson's disease.
    Lipman IJ
    Va Med Mon (1918); 1971 May; 98(5):242-8. PubMed ID: 4931138
    [No Abstract]   [Full Text] [Related]  

  • 7. Parkinsonism.
    Shimomura SK
    J Am Pharm Assoc; 1972 Jan; 12(1):29-36. PubMed ID: 4399879
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug therapy of Parkinson's diseases].
    Lhermitte F; Degos CF
    Acquis Med Recent; 1972; ():73-80. PubMed ID: 4667798
    [No Abstract]   [Full Text] [Related]  

  • 9. [Recent advances and pharmacological basis of the medical treatment of Parkinson's syndrome].
    Shibazaki H
    Shinkei Kenkyu No Shimpo; 1971; 15(4):992-1002. PubMed ID: 4400830
    [No Abstract]   [Full Text] [Related]  

  • 10. Current concepts in the management of Parkinson's disease.
    Chapman WG
    West Indian Med J; 1974 Mar; 23(1):61-4. PubMed ID: 4456821
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor (Ro 4-4602). Course in 71 patients].
    Ferel D
    Schweiz Med Wochenschr; 1972 Jan; 102(3):88-94. PubMed ID: 4551909
    [No Abstract]   [Full Text] [Related]  

  • 12. [Conservative therapy in the Parkinson syndrome].
    Birkmayer W
    Wien Med Wochenschr; 1971 Nov; 121(46):827-9. PubMed ID: 5138823
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug therapy of parkinsonism.
    Yahr MD; Duvoisin RC
    N Engl J Med; 1972 Jul; 287(1):20-4. PubMed ID: 4555145
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of Parkinson's syndrome with L-dopa].
    Kaeser HE; Ferel D; Wurmser P
    Schweiz Med Wochenschr; 1970 May; 100(19):805-13. PubMed ID: 4924276
    [No Abstract]   [Full Text] [Related]  

  • 15. [Review of current pharmacotherapy of Parkinsonism. Comprehensive review].
    Benesová O
    Cesk Neurol; 1973 May; 36(3):196-205. PubMed ID: 4574253
    [No Abstract]   [Full Text] [Related]  

  • 16. [Preliminary observations on the use of intravenous amantadine and of the association of oral amantadine with anticholinergic drugs and with levo-dopa in the treatment of Parkinson's disease].
    Fasano VA; Urciuoli R; Broggi G
    Minerva Med; 1970 Jul; 61(53):2895-903. PubMed ID: 5428170
    [No Abstract]   [Full Text] [Related]  

  • 17. Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease.
    Andrews CJ; Somerville B
    Med J Aust; 1974 Mar; 1(12):429-32. PubMed ID: 4598384
    [No Abstract]   [Full Text] [Related]  

  • 18. L-Dopa therapy in Parkinson's disease.
    Greer M
    J Fla Med Assoc; 1970 Jun; 57(6):23-7. PubMed ID: 4392779
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of Parkinson's disease with L-dopa combined with a decarboxylase inhibitor].
    Siegfried J; Klaiber R; Perret E; Ziegler WH
    Dtsch Med Wochenschr; 1969 Dec; 94(52):2678-81. PubMed ID: 4903342
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dopa and decarboxylase inhibitors in Parkinson's disease].
    Pakkenberg H
    Ugeskr Laeger; 1974 Feb; 136(7):377. PubMed ID: 4821980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.